LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.
Platelet-activating factor (PAF) is a bioactive phospholipid that accumulates during ischemia-reperfusion and is involved in the activation of platelets, neutrophils, and pro-inflammatory signaling. PAF has been suggested to enhance brain ischemia-reperfusion damage. LAU-0901, a novel PAF receptor antagonist, was examined in models of focal cerebral ischemia in rats and mice. Sprague-Dawley rats were anesthetized and received 2-hour middle cerebral artery occlusion (MCAo) by intraluminal suture. LAU-0901 (30, 60, 90 mg/kg; n=9-11) or vehicle (n=11) was administered i.p. at 2 h after onset of MCAo. The neurological status was evaluated at 60 min, and on days 1, 2, 3 and 7 after MCAo. In the dose-response study in mice, C57BL/6 mice were anesthetized and received 1 h MCAo by intraluminal suture. LAU-0901 (15, 30, 60 mg/kg; n=7-9) or vehicle (n=8) was given i.p. at 1 h after onset of MCAo. Local cerebral blood flow (LCBF) was measured at 1, 2, 4, and 6 h after MCAo in mice. LAU-0901 treated rats showed improved neurological score throughout the 7-day survival period. LAU-0901 treatment (30, 60 and 90 mg/kg) reduced total corrected infarct volume compared to vehicle rats by 76, 88 and 90%, respectively. Mice treated with LAU-0901 (30 and 60 mg/kg) reduced total infarction by 29% and 66%, respectively. LCBF was improved by treatment with LAU-0901 (30 mg/kg) by 77% of baseline at 6 h. In conclusion, we demonstrate for the first time that LAU-0901 improves behavioral scores, LCBF and reduces infarct volume after focal cerebral ischemia in rats and mice. Thus, this PAF receptor antagonist exhibits potent and sustained neuroprotection that may be of value for the design of stroke therapies.
Belayev
Ludmila
L
Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA. lbelay@lsuhsc.edu
Khoutorova
Larissa
L
Atkins
Kristal
K
Gordon
William C
WC
Alvarez-Builla
Julio
J
Bazan
Nicolas G
NG
D000208:Acute Disease; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002545:Brain Ischemia / Q000188:drug therapy* / Q000473:pathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004095:Dihydropyridines / Q000737:chemistry / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D020244:Infarction, Middle Cerebral Artery / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D019579:Neocortex / Q000098:blood supply / Q000473:pathology; D018696:Neuroprotective Agents / Q000737:chemistry / Q000494:pharmacology*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D051381:Rats; D017207:Rats, Sprague-Dawley
D004095:Dihydropyridines; C487837:LAU 0901; D018696:Neuroprotective Agents; D010972:Platelet Activating Factor
Neurosci Lett. 2007 Oct 9;426(1):59-63
17881124
Can J Cardiol. 2000 Apr;16(4):497-504
10787465
Brain Res. 2007 Apr 27;1143:193-8
17320823
Neuroreport. 2007 Jan 22;18(2):115-9
17301674
Ann N Y Acad Sci. 2005 Aug;1053:455-6
16179552
Nephrol Dial Transplant. 2001 Apr;16(4):735-41
11274266
Stroke. 2001 Nov;32(11):2675-81
11692033
Stroke. 1996 Jun;27(6):1112-7
8650723
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):883-91
16505020
J Cereb Blood Flow Metab. 1987 Dec;7(6):729-38
3693428
Mol Neurobiol. 2005 Aug;32(1):89-103
16077186
J Neurophysiol. 2002 Jun;87(6):2851-7
12037188
J Neurosurg. 2000 Jan;92(1):91-9
10616087
J Biol Chem. 2003 Oct 31;278(44):43807-17
12923200
Am J Med. 2000 Sep;109(4):315-23
10996583
Exp Eye Res. 2005 Dec;81(6):742-50
15979612
J Lipid Res. 2003 Dec;44(12):2221-33
13130128
Stroke. 1989 Jan;20(1):84-91
2643202
Stroke. 1986 May-Jun;17(3):472-6
3715945
Ann Neurol. 2006 Mar;59(3):467-77
16453316
J Biol Chem. 1999 Mar 5;274(10):6493-8
10037742
Metab Brain Dis. 1997 Sep;12(3):237-49
9346472
Prostaglandins Other Lipid Mediat. 2005 Sep;77(1-4):65-76
16099392
Int J Angiol. 2001 Jan;10(1):10-14
11178779
Stroke. 2003 Mar;34(3):758-63
12624304
Ann N Y Acad Sci. 1989;559:340-51
2774404
Stroke. 1989 Oct;20(10):1383-90
2799870
Indian J Exp Biol. 2006 Nov;44(11):886-91
17205708
Proc Natl Acad Sci U S A. 1995 May 23;92(11):5047-51
7761446
Nature. 1994 Jan 13;367(6459):175-9
8114914
Stroke. 1998 Feb;29(2):529-34
9472901
Stroke. 1996 Sep;27(9):1616-22; discussion 1623
8784138
Br J Pharmacol. 2003 Jun;139(4):733-40
12812996